Empagliflozin and Metformin Extended-Release Tablets and Siltuximab Intravenous
Determining the interaction of Empagliflozin and Metformin Extended-Release Tablets and Siltuximab Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: empagliflozin / metformin
Brand name: Synjardy, Synjardy XR
Synonyms: Empagliflozin and metformin, Empagliflozin and Metformin
Generic Name: siltuximab
Brand name: Sylvant
Synonyms: Siltuximab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Empagliflozin and Metformin Extended-Release Tablets-Silvadene
- Empagliflozin and Metformin Extended-Release Tablets-Silvadene Topical
- Empagliflozin and Metformin Extended-Release Tablets-SilvaSorb
- Empagliflozin and Metformin Extended-Release Tablets-Silver
- Empagliflozin and Metformin Extended-Release Tablets-Silver Nitrate
- Empagliflozin and Metformin Extended-Release Tablets-Silver Nitrate Applicators
- Siltuximab Intravenous-Empagliflozin and Metformin Tablets
- Siltuximab Intravenous-Empliciti
- Siltuximab Intravenous-Emsam
- Siltuximab Intravenous-Emsam Transdermal
- Siltuximab Intravenous-Emtricitabine
- Siltuximab Intravenous-Emtricitabine and tenofovir